Literature DB >> 4037989

Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course.

H S Akiskal, J Downs, P Jordan, S Watson, D Daugherty, D B Pruitt.   

Abstract

We studied 68 referred juvenile offspring or siblings of adult bipolar patients. Mean age at onset of affective and related disturbances was 15.9 years (range, 6 to 24 years). Although four of the ten prepubertal children had hypomanic features, full-blown manic psychosis did not appear before puberty. In the sample at large, 12 were classified as dysthymic and ten as cyclothymic. Eleven additional subjects with polysubstance abuse, who at onset did not meet criteria for affective disorder, were reclassified as having either a dysthymic or a cyclothymic disorder during follow-up. Of the remaining patients--24 depressive, eight manic, and three mixed state--71% experienced recurrences; mood-incongruent features, present in four cases at onset, recurred in only one patient during subsequent episodes. Overall, half the sample evidenced signs of bipolarity during a mean prospective follow-up period of three years.

Entities:  

Mesh:

Year:  1985        PMID: 4037989     DOI: 10.1001/archpsyc.1985.01790330076009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  32 in total

1.  Dimensional endophenotypes in bipolar disorder: affective dysregulation and psychosis proneness.

Authors:  K Mahon; M M Perez-Rodriguez; N Gunawardane; K E Burdick
Journal:  J Affect Disord       Date:  2013-08-14       Impact factor: 4.839

2.  Characteristics of depression among offspring at high and low familial risk of bipolar disorder.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; Brian Thomas Rooks; Dara Sakolsky; Benjamin I Goldstein; Kelly Monk; Mary Beth Hickey; David Axelson; Satish Iyengar; Boris Birmaher
Journal:  Bipolar Disord       Date:  2017-06-14       Impact factor: 6.744

3.  Genome-wide association study of temperament in bipolar disorder reveals significant associations with three novel Loci.

Authors:  Tiffany A Greenwood; Hagop S Akiskal; Kareen K Akiskal; John R Kelsoe
Journal:  Biol Psychiatry       Date:  2012-02-23       Impact factor: 13.382

Review 4.  The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents.

Authors:  Marta Hauser; Christoph U Correll
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

5.  Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed?

Authors:  Anna R Van Meter; Eric A Youngstrom
Journal:  Neuropsychiatry (London)       Date:  2012-12-01

6.  Personality disorders in offspring of mothers with mood disorders: results from a longitudinal family study.

Authors:  Kathryn R Cullen; Lynn E Eberly; Monika D Heller; Amanda Schlesinger; Phillip W Gold; Pedro E Martinez; Bonnie Klimes-Dougan
Journal:  Psychiatry Res       Date:  2014-05-09       Impact factor: 3.222

7.  [Early recognition and intervention for bipolar disorders: state of research and perspectives].

Authors:  A Pfennig; C U Correll; K Leopold; G Juckel; M Bauer
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

8.  Mood and disruptive behavior disorders and symptoms in the offspring of patients with bipolar I disorder.

Authors:  F Neslihan Inal-Eiroglu; Aysegul Ozerdem; David Miklowitz; Aysen Baykara; Aynur Akay
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

9.  Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study.

Authors:  Timothy E Wilens; Joseph Biederman; Joel J Adamson; Aude Henin; Stephanie Sgambati; Martin Gignac; Robert Sawtelle; Alison Santry; Michael C Monuteaux
Journal:  Drug Alcohol Depend       Date:  2008-03-17       Impact factor: 4.492

10.  The early course of bipolar disorder in youth at familial risk.

Authors:  Anne Duffy
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.